Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric Artemisia-Scutellaria Anti-Cold Granules in Upper Respiratory Infection
CTR20170783Phase 2Active
- Sponsor
- Yusen Pharma
- Start
- Nov 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Xiao'er Haoqin Kanggan Granules in upper respiratory infection (URI), sponsored by Yusen Pharma. Started Nov 2017; status: active.
02
Drugs
Xiao'er Haoqin Kanggan Granules
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on CTR20170783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170783.